Regression Rates of CIN 2/CIN 3 in Women under 25 Years Old

被引：0
|
作者：
Bark, V [1 ]
Mondal, A. [1 ]
Hampl, M. [1 ]
机构：
[1] Klin Frauenheilkunde & Geburtshilfe, Dusseldorf, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2020年 / 80卷 / 10期
关键词：
D O I：
10.1055/s-0040-1718120
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P291
引用
收藏
页码：E184 / E184
页数：1
相关论文
共 50 条
  • [11] Justifying conservative management of CIN2 in women younger than 25 years - A population-based study
    Loopik, Diede L.
    Bekkers, Ruud L. M.
    Massuger, Leon F. A. G.
    Melchers, Willem J. G.
    Siebers, Albert G.
    Bentley, James
    GYNECOLOGIC ONCOLOGY, 2019, 152 (01) : 82 - 86
  • [12] Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine
    E García-Hernández
    J L González-Sánchez
    A Andrade-Manzano
    M L Contreras
    S Padilla
    C C Guzmán
    R Jiménez
    L Reyes
    G Morosoli
    M L Verde
    R Rosales
    Cancer Gene Therapy, 2006, 13 : 592 - 597
  • [13] CORRELATION BETWEEN BIOPSY AND CONIZATION SPECIMEN IN PATIENTS WITH CIN 2 VS CIN 3
    Medina, N.
    Benito, V.
    Carballo, S.
    Santana, J.
    Esparza, M.
    Arencibia, O.
    Leon, L.
    Andujar, M.
    Lubrano, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 961 - 961
  • [14] Why CIN3 and CIN2 should be distinguished on histological reports
    Herbert, A.
    Arbyn, M.
    Bergeron, C.
    CYTOPATHOLOGY, 2008, 19 (01) : 63 - 64
  • [15] Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine
    Garcia-Hernandez, E.
    Gonzalez-Sanchez, J. L.
    Andrade-Manzano, A.
    Contreras, M. L.
    Padilla, S.
    Guzman, C. C.
    Jimenez, R.
    Reyes, L.
    Morosoli, G.
    Kerde, M. L.
    Rosales, R.
    CANCER GENE THERAPY, 2006, 13 (06) : 592 - 597
  • [16] Why young women should be screened for cervical cancer: the distinction between CIN2 and CIN3 Response
    Sasieni, Peter
    Castanon, Alejandra
    Parkin, Max D.
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (09) : 2257 - 2258
  • [17] Conservative management of CIN2 in women below 35 years: A retrospective study
    Chatterjee, Bidisha
    Prasad, Malini
    Judd, Michelle
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 : 47 - 47
  • [18] Rates of High Grade Histology (CIN Grade 2 or 3) in Women Over 30 Years Referred with Low Grade Cervical Cytology and the Role of hrHPV
    Adams, F.
    Sykes, P.
    Simcock, B.
    Macnab, H.
    Innes, C.
    Scowcroft, H.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2017, 57 : 23 - 24
  • [19] Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models
    Syrjanen, K.
    Shabalova, I.
    Sarian, L.
    Naud, P.
    Longatto-Filho, A.
    Derchain, S.
    Kozachenko, V.
    Zakharchenko, S.
    Roteli-Martins, C.
    Nerovjna, R.
    Kljukina, L.
    Tatti, S.
    Branovskaja, M.
    Branca, M.
    Grunjberga, V.
    Erzen, M.
    Juschenko, A.
    Hammes, L. Serpa
    Podistov, J.
    Costa, S.
    Syrjanen, S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2012, 33 (01) : 5 - 14
  • [20] Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression
    Ovestad, Irene Tveiteras
    Gudlaugsson, Einar
    Skaland, Ivar
    Malpica, Anais
    Kruse, Arnold-Jan
    Janssen, Emiel A. M.
    Baak, Jan P. A.
    MODERN PATHOLOGY, 2010, 23 (09) : 1231 - 1240
12345